BIO Statement on MedPAC Vote

Washington, DC (April 6, 2017) – The Biotechnology Innovation Organization (BIO) issued the following statement regarding today's Medicare Payment Advisory Commission (MedPAC) vote:

Congresswoman Sinema Honored as BIO Legislator of the Year

Arizona Congresswoman Kyrsten Sinema was named a 2017 BIO Legislator of the Year

BIO Celebrates Five Years of the JOBS Act

Today the Biotechnology Innovation Organization (BIO) celebrates the fifth anniversary of the Jumpstart Our Business Startups (JOBS) Act, which was signed into law on April 5, 2012.  

Quality Metrics: BIO Comments on FDA Revised Draft Guidance "Submission of Quality Metrics Data"

The Biotechnology Innovation Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to submit comments on FDA’s Revised Draft Guidance for Industry Submission of Quality Metrics Data (Revised Draft Guidance).

BIO Brings Worldwide Life Sciences Community Back to San Diego

Registration Now Open for International Convention Set for June 19-22

Biotech Leader Testifies Before House Capital Markets Subcommittee

Washington, DC (March 22, 2017) – Brian Hahn, Chief Financial Officer of GlycoMimetics, Inc., provided testimony today on behalf of the Biotechnology Innovation Organization (BIO) before the House Subcommittee on Capital Markets and Government Sponsored Enterprises. Hahn serves as the Co-Chair of BIO’s Finance & Tax Committee.

BIO Announces Plenary Sessions for 2017 World Congress on Industrial Biotechnology

BIO has officially released the list of speakers for plenary programs at the 2017 World Congress on Industrial Biotechnology. The sessions will feature executives from the biofuels, household and personal care, and airline industries who will discuss technology breakthroughs, business partnerships and sustainability initiatives. The world’s largest industrial biotechnology event will be held July 23-26, 2017 at the Palais des congrès de Montréal in Montréal, Québec, Canada. 

BIO Praises Reps. Sinema and Hollingsworth for Introducing the Fostering Innovation Act

Washington, DC (March 22, 2017) – Today, the Biotechnology Innovation Organization (BIO) applauds Reps. Kyrsten Sinema (D-AZ) and Trey Hollingsworth (R-IN) for introducing the Fostering Innovation Act. The legislation would reduce compliance costs for growing businesses that benefitted from the JOBS Act.

BIO Statement on President’s Budget Proposal

Washington, DC (March...

Re: FDA-2016-N-4389: Genome Editing in New Plant Varieties Used for Foods; Request for Comment

March 9, 2017